Supernus Pharmaceuticals Ratios (2011-2025) | SUPN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Profitability
Gross Margin											97.37%	89.67%	94.56%	94.40%	94.18%	92.69%	94.37%	95.06%	94.29%	93.60%	95.40%	94.67%	93.97%	93.95%	94.88%	94.91%	94.71%	95.30%	96.38%	96.30%	95.92%	96.39%	95.69%	96.14%	95.28%	95.91%	95.63%	93.38%	86.21%	87.09%	88.58%	82.29%	87.82%	89.32%	88.24%	87.97%	85.41%	86.28%	84.74%	84.44%	87.26%	88.06%	88.65%	89.36%	89.99%	85.01%	89.48%	89.83%	90.13%
EBT Margin	2,650.83%	1,780.16%	-94,645.45%	-25,238.10%	-4,240.87%	-11,158.24%	-14,429.67%	-1,240.18%	-12,641.50%	-6,251.96%	-1,587.03%	-129.36%	-171.16%	10.79%	-10.45%	14.14%	2.87%	7.46%	10.31%	16.17%	11.37%	20.64%	33.68%	24.93%	28.18%	34.85%	28.50%	39.64%	34.48%	34.01%	35.31%	33.44%	28.36%	40.83%	38.76%	40.73%	30.57%	37.25%	33.98%	27.65%	8.35%	22.10%	19.51%	1.29%	9.65%	6.66%	-0.25%	21.00%	5.86%	-12.63%	6.43%	0.60%	0.17%	15.63%	25.58%	15.15%	-3.89%	10.07%	-30.17%
EBIT Margin	2,555.00%	1,682.57%	-90,136.36%	-24,390.48%	-3,787.50%	-10,172.53%	-13,505.49%	-1,169.08%	-12,182.31%	-5,508.54%	-1,366.35%	-109.90%	-147.80%	12.66%	-3.24%	16.41%	14.04%	10.77%	12.92%	18.04%	14.57%	22.56%	34.92%	26.13%	29.16%	34.38%	27.79%	38.84%	34.72%	35.89%	36.38%	34.38%	29.75%	40.69%	38.90%	40.63%	30.55%	35.94%	36.19%	29.95%	10.09%	24.14%	21.96%	3.83%	1.29%	6.67%	-0.86%	20.52%	3.37%	-12.97%	5.29%	-0.61%	-2.20%	13.41%	23.25%	12.29%	-6.85%	7.34%	-31.35%
EBITDA Margin	2,555.00%	1,682.57%	-90,136.36%	-24,390.48%	-3,787.50%	-10,172.53%	-13,505.49%	-1,169.08%	-12,182.31%	-5,508.54%	-1,366.35%	-109.90%	-147.80%	12.66%	-3.24%	16.41%	14.04%	10.77%	12.92%	18.04%	14.57%	22.56%	34.92%	26.13%	29.16%	34.38%	27.79%	38.84%	34.72%	35.89%	36.38%	34.38%	29.75%	40.69%	38.90%	40.63%	30.55%	35.94%	36.19%	29.95%	10.09%	24.14%	21.96%	3.83%	1.29%	6.67%	-0.86%	20.52%	3.37%	-12.97%	5.29%	-0.61%	-2.20%	13.41%	23.25%	12.29%	-6.85%	7.34%	-31.35%
Operating Margin	2,555.00%	1,682.57%	-90,136.36%	-24,390.48%	-3,787.50%	-10,172.53%	-13,505.49%	-1,169.08%	-12,182.31%	-5,508.54%	-1,366.35%	-109.90%	-147.80%	12.66%	-3.24%	16.41%	14.04%	10.77%	12.92%	18.04%	14.57%	22.56%	34.92%	26.13%	29.16%	34.38%	27.79%	38.84%	34.72%	35.89%	36.38%	34.38%	29.75%	40.69%	38.90%	40.63%	30.55%	35.94%	36.19%	29.95%	10.09%	24.14%	21.96%	3.83%	1.29%	6.67%	-0.86%	20.52%	3.37%	-12.97%	5.29%	-0.61%	-2.20%	13.41%	23.25%	12.29%	-6.85%	7.34%	-31.35%
Net Margin	3,307.50%	1,650.30%	-96,290.91%	193,138.10%	-4,872.60%	-11,317.58%	-14,815.38%	-1,239.72%	-12,526.53%	-9,735.59%	-1,916.95%	-216.82%	-171.16%	10.79%	-10.45%	14.14%	2.57%	6.83%	9.95%	15.68%	10.92%	19.86%	108.83%	22.96%	17.88%	22.90%	19.85%	15.44%	29.14%	30.88%	27.20%	22.33%	21.46%	31.26%	28.26%	32.98%	22.66%	27.36%	25.78%	21.43%	4.35%	16.79%	14.52%	1.54%	16.80%	4.60%	0.99%	15.23%	11.02%	-0.61%	-10.40%	0.72%	0.09%	11.82%	21.91%	8.83%	-7.90%	13.60%	-23.49%
FCF Margin	3,264.72%	1,667.74%	-95,336.36%	-19,830.95%	-4,859.62%	-10,779.12%	-12,851.65%	-1,499.08%	-11,969.39%	-5,843.42%	-1,267.06%	-93.41%	-213.27%	-23.78%	-21.19%	19.67%	-1.58%	34.72%	3.61%	43.64%	-7.74%	31.29%	49.01%	39.50%	22.68%	33.48%	47.99%	40.23%	29.72%	6.28%	60.45%	28.25%	38.34%	27.38%	36.42%	41.58%	6.72%	72.14%	3.50%	22.09%	27.65%	32.74%	-2.77%	30.66%	2.26%	41.98%	7.80%	16.57%	31.77%	-14.04%	23.22%	27.38%	26.56%	21.13%	30.35%	25.38%	20.21%	35.10%	-32.17%
Efficiency
Inventory Average								0.59M	2.13M	3.71M	4.75M	6.17M	7.55M	9.03M	10.62M	12.29M	13.57M	13.65M	14.17M	13.66M	12.82M	14.71M	16.91M	17.13M	17.98M	17.89M	15.79M	15.63M	17.69M	19.88M	21.98M	24.47M	26.09M	26.27M	25.76M	26.07M	25.52M	29.88M	38.90M	45.40M	49.28M	54.31M	59.27M	73.06M	87.38M	86.83M	84.01M	87.35M	91.34M	90.85M	87.02M	80.44M	76.24M	71.62M	66.07M	59.14M	51.86M	46.72M	61.71M
Assets Average					48.47M	61.58M	73.49M	80.50M	86.53M	105.52M	127.87M	117.38M	104.26M	95.86M	109.88M	131.17M	138.09M	146.71M	160.33M	177.63M	191.55M	206.55M	251.87M	297.34M	315.91M	334.31M	365.92M	404.97M	624.81M	838.98M	887.66M	950.16M	1,001.63M	1,044.56M	1,085.29M	1,133.60M	1,175.07M	1,340.44M	1,500.52M	1,507.06M	1,505.77M	1,540.25M	1,564.05M	1,622.10M	1,664.33M	1,667.24M	1,694.05M	1,697.82M	1,747.16M	1,542.45M	1,289.13M	1,281.42M	1,290.88M	1,309.96M	1,329.27M	1,355.39M	1,357.68M	1,364.85M	1,401.08M
Equity Average					4.86M	19.13M	31.31M	41.10M	49.42M	38.58M	24.17M	22.96M	31.24M	31.19M	34.68M	38.35M	52.23M	67.79M	75.20M	83.30M	92.56M	103.67M	141.80M	182.56M	198.91M	217.73M	240.53M	260.73M	310.84M	371.18M	406.21M	437.48M	466.52M	501.46M	540.08M	576.34M	604.41M	639.68M	687.43M	726.87M	749.65M	770.01M	798.02M	813.16M	822.15M	834.94M	847.12M	869.50M	899.18M	916.03M	916.05M	916.85M	925.34M	943.31M	982.30M	1,021.44M	1,033.22M	1,047.30M	1,056.78M
Invested Capital				16.22M	9.45M	48.73M	36.12M	69.38M	53.41M	35.89M	12.45M	33.46M	29.01M	33.37M	35.99M	40.70M	63.75M	71.82M	78.59M	88.01M	97.11M	110.22M	173.37M	191.75M	206.06M	229.40M	251.66M	269.80M	754.37M	792.99M	824.44M	855.52M	882.52M	522.90M	557.26M	595.43M	613.38M	689.47M	791.78M	775.76M	785.96M	809.12M	834.04M	1,195.10M	875.34M	1,242.34M	1,254.24M	907.32M	990.51M	940.63M	958.07M	973.59M	980.54M	1,004.76M	1,053.73M	1,083.07M	1,060.70M	1,063.90M	1,060.90M
Asset Utilization Ratio					0.00	0.01	0.01	0.02	0.02	0.02	0.02	0.10	0.20	0.53	0.65	0.71	0.81	0.81	0.84	0.83	0.85	0.87	0.78	0.72	0.72	0.76	0.75	0.75	0.54	0.43	0.43	0.43	0.40	0.39	0.38	0.35	0.34	0.32	0.32	0.35	0.37	0.37	0.36	0.36	0.36	0.38	0.39	0.39	0.38	0.41	0.47	0.47	0.46	0.48	0.49	0.49	0.49	0.49	0.49
Leverage & Solvency
Interest Coverage Ratio	-25.55	-16.83	-19.87	-20.13	-8.19	-9.96	-13.97	-15.85	-24.63	-7.22	-5.98	-5.39	-11.12	2.94	-0.57	4.31	10.59	11.61	17.41	35.02	35.96	59.41	98.21	-479.29	186.53	449.43	0.02M	24.19	43.79	8.26	8.57	4.58	4.33	7.90	7.02	7.07	5.04	7.83	9.22	7.05	2.17	6.24	5.50	1.03	1.01	6.27	-0.88	21.54	3.44	-19.33
Debt to Equity				3.12	106.19	0.73	1.04	0.40	0.49																													0.04	0.12	0.04	0.04	0.03	0.03	0.52	0.06	0.48	0.47	0.02	0.09	0.02	0.05	0.06	0.06	0.05	0.05	0.05	0.03		0.01
Debt Ratio				0.55	0.67	0.35	0.38	0.24	0.25																													0.02	0.05	0.02	0.02	0.01	0.02	0.25	0.03	0.24	0.24	0.01	0.04	0.02	0.04	0.04	0.04	0.04	0.03	0.03	0.02		0.01
Equity Ratio				0.18	0.01	0.47	0.37	0.61	0.52	0.27	0.10	0.30	0.30	0.35	0.29	0.30	0.46	0.47	0.47	0.47	0.50	0.50	0.61	0.62	0.64	0.66	0.65	0.64	0.43	0.46	0.46	0.46	0.47	0.49	0.50	0.51	0.52	0.45	0.47	0.50	0.50	0.50	0.52	0.48	0.51	0.50	0.50	0.52	0.51	0.71	0.71	0.72	0.71	0.73	0.75	0.76	0.77	0.77	0.74
Times Interest Earned	-25.55	-16.83	-19.87	-20.13	-8.19	-9.96	-13.97	-15.85	-24.63	-7.22	-5.98	-5.39	-11.12	2.94	-0.57	4.31	10.59	11.61	17.41	35.02	35.96	59.41	98.21	-479.29	186.53	449.43	0.02M	24.19	43.79	8.26	8.57	4.58	4.33	7.90	7.02	7.07	5.04	7.83	9.22	7.05	2.17	6.24	5.50	1.03	1.01	6.27	-0.88	21.54	3.44	-19.33
Valuation
Enterprise Value	-20.84M	-16.56M	-16.48M	-48.54M	-37.38M	151.83M	221.89M	87.37M	103.72M	96.60M	139.55M	172.99M	269.10M	413.14M	300.42M	281.99M	468.20M	741.22M	622.00M	595.34M	708.10M	946.50M	1,144.02M	1,159.97M	1,482.95M	2,074.21M	1,913.41M	1,902.76M	1,870.68M	2,925.61M	2,348.77M	1,379.96M	1,540.37M	1,474.83M	1,144.60M	897.35M	544.22M	872.98M	745.57M	903.02M	994.43M	1,222.60M	973.55M	1,211.07M	1,406.60M	1,183.92M	1,419.03M	1,466.92M	1,741.51M	1,485.90M	1,304.98M	1,326.20M	1,569.27M	1,123.37M	1,314.98M	1,543.12M	1,364.33M	1,242.20M	2,398.57M
Market Capitalization						228.22M	282.56M	175.88M	173.61M	199.24M	226.79M	255.18M	327.96M	460.41M	372.99M	356.32M	533.04M	811.01M	679.70M	657.53M	753.36M	1,006.71M	1,224.34M	1,250.09M	1,570.09M	2,167.17M	2,027.96M	2,042.80M	2,360.40M	3,100.02M	2,628.99M	1,735.98M	1,833.31M	1,733.39M	1,441.30M	1,244.42M	945.09M	1,247.79M	1,097.52M	1,325.56M	1,385.53M	1,632.44M	1,417.40M	1,550.75M	1,718.80M	1,544.71M	1,810.81M	1,928.25M	1,970.08M	1,637.56M	1,505.17M	1,581.07M	1,867.01M	1,470.56M	1,718.19M	1,996.73M	1,827.92M	1,764.79M	2,679.73M
Return Ratios
Return on Sales				-95.58%	-292.24%	164.31%	102.52%	-30.83%	-39.03%	-39.03%	-25.09%	-5.78%	-3.17%	-0.91%	-0.39%	-0.11%	0.05%	0.04%	0.09%	0.09%	0.11%	0.14%	0.43%	0.42%	0.42%	0.41%	0.21%	0.19%	0.22%	0.24%	0.26%	0.27%	0.25%	0.26%	0.26%	0.29%	0.29%	0.28%	0.27%	0.24%	0.20%	0.18%	0.14%	0.09%	0.12%	0.09%	0.06%	0.09%	0.08%	0.07%	0.04%	0.00%	-0.03%	0.01%	0.09%	0.11%	0.09%	0.10%	-0.03%
Return on Capital Employed					-1.28%	-0.94%	-0.81%	-0.73%	-0.88%	-0.65%	-0.62%	-0.68%	-0.74%	-0.50%	-0.25%	-0.05%	0.11%	0.11%	0.16%	0.17%	0.17%	0.22%	0.25%	0.25%	0.28%	0.32%	0.31%	0.35%	0.23%	0.17%	0.19%	0.18%	0.16%	0.16%	0.16%	0.15%	0.15%	0.14%	0.14%	0.14%	0.12%	0.12%	0.09%	0.07%	0.05%	0.06%	0.02%	0.05%	0.05%	0.02%	0.03%	-0.01%	-0.01%	0.03%	0.06%	0.08%	0.07%	0.06%	-0.03%
Return on Invested Capital																				0.24%	0.24%	0.29%					0.24%	0.22%	0.14%	0.11%	0.12%	0.14%	0.12%	0.15%	0.20%	0.20%	0.19%	0.18%	0.18%	0.17%	0.15%	0.14%	0.11%	0.06%	0.07%			0.04%	0.05%		0.02%	0.00%		0.00%	0.05%	0.06%	0.05%	0.05%	-0.03%
Return on Assets					1.44%	0.94%	0.60%	-0.57%	-0.64%	-0.60%	-0.54%	-0.59%	-0.64%	-0.48%	-0.26%	-0.08%	0.04%	0.04%	0.07%	0.08%	0.09%	0.13%	0.33%	0.31%	0.31%	0.31%	0.16%	0.14%	0.12%	0.10%	0.11%	0.12%	0.10%	0.10%	0.10%	0.10%	0.10%	0.09%	0.09%	0.08%	0.07%	0.07%	0.05%	0.03%	0.04%	0.03%	0.02%	0.04%	0.03%	0.03%	0.02%	0.00%	-0.01%	0.00%	0.04%	0.05%	0.05%	0.05%	-0.01%
Return on Equity					14.32%	3.02%	1.41%	-1.11%	-1.12%	-1.63%	-2.88%	-3.03%	-2.13%	-1.46%	-0.81%	-0.27%	0.11%	0.08%	0.15%	0.17%	0.19%	0.25%	0.59%	0.50%	0.49%	0.48%	0.24%	0.22%	0.24%	0.23%	0.24%	0.25%	0.22%	0.21%	0.20%	0.20%	0.19%	0.18%	0.19%	0.17%	0.15%	0.13%	0.10%	0.07%	0.09%	0.07%	0.04%	0.07%	0.06%	0.05%	0.03%	0.00%	-0.02%	0.01%	0.06%	0.07%	0.06%	0.06%	-0.02%

Research Tools

Supernus Pharmaceuticals Ratios (2011-2025) | SUPN

Create an account

Sign In

Reset Password

Get Pro for 60% off